Metabolgenomics
November 15, 2011 | Terry Sharrer
Metabolic syndrome-that dangerous mix of hypertension, elevated cholesterol and Type 2 diabetes-is both biologically complex and rising in incidence as the developed world’s population ages. Numerous biomarkers exist for each face of this syndrome, and further, the biomarkers interact with each other. Identifying these interactions and finding previously unknown loci in genome wide association studies has been the aim of a collaboration between British and Germany researchers who reported sixteen previously unknown genetic risk locations. MORE